Skip to Content

ZE67 (Glipizide and Metformin Hydrochloride 2.5 mg / 500 mg)

Pill with imprint ZE67 is White, Capsule-shape and has been identified as Glipizide and Metformin Hydrochloride 2.5 mg / 500 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZE67

Glipizide and metformin hydrochloride 2.5 mg / 500 mg ZE67

Glipizide and Metformin Hydrochloride

Imprint
ZE67
Strength
2.5 mg / 500 mg
Color
White
Size
15.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
National Drug Code (NDC)
65841-0660
Inactive Ingredients
croscarmellose sodium, hypromelloses, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, titanium dioxide, polysorbate 80

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.